Clinical Trial Update: Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure [Phase 2]

View source ↗

Summary

Phase 2 trial of pasireotide for treating gastrointestinal angiodysplasia in patients with endoscopic treatment failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Angiodysplasia

Drugs mentioned

• Pasireotide (pasireotide)

Snippet

Sponsor: Robert Benamouzig | Conditions: Angiodysplasia | Phase 2 | Status: COMPLETED